DOCSLIB.ORG

Infusion Therapy Standards of Practice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Supplement to January/February 2016 Volume 39, Number 1S ISSN 1533-1458 www.journalofi nfusionnursing.com Infusion Therapy Standards of Practice Funded by an educational grant from BD Medical NANv39n1S-Cover.indd 1 31/12/15 4:27 PM 31/12/15 4:27 PM Volume 39, Number 1S Supplement to Journal of Infusion Nursing January/February 2016 NANv39n1S-Cover.indd 2 Seamless Patient Care, with an IV Catheter that Lasts BD Nexiva™ Closed IV Catheter System Longer dwell times can reduce painful restarts. Let’s admit it. Few people look forward to having an IV catheter placed. Patients don’t like it. Clinicians don’t enjoy it. And all that is compounded when a catheter fails or has to be replaced. Use of the BD Nexiva™ Closed IV Catheter System enables longer dwell times and clinically indicated catheter replacement.1* A 2014 clinical study demonstrated that BD Nexiva™ catheters had a median dwell time of 144 hours for catheters in place ≥24 hours.1* The same study showed that longer dwell times of closed systems led to a cost reduction of approximately $1M/year/1,000 beds compared to an open system.1 That’s good for you and for your patients. To order or learn about all the ways BD is caring for you and your patients, visit bd.com/INS today or call (888) 237-2762. * Compared to 96 hours with an open system. 1 González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications BD Medical and costs of open vs closed safety peripheral intravenous catheters: a randomized study. 9450 South State Street J Hosp Infect. 2014;86(2):117-126. Sandy, Utah 84070 BD, BD Logo and BD Nexiva are trademarks of Becton, Dickinson and Company. 1-888-237-2762 © 2015 BD MSS0932 (12/15) www.bd.com/INS NAN3901S-IFC.indd 2 31/12/15 3:38 PM INFUSION THERAPY STANDARDS OF PRACTICE Developed by Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN Lynn Hadaway, MEd, RN-BC, CRNI® Mary E. Hagle, PhD, RN-BC, FAAN Mary McGoldrick, MS, RN, CRNI® Marsha Orr, MS, RN Darcy Doellman, MSN, RN, CRNI®, VA-BC REVISED 2016 315 Norwood Park South, Norwood, MA 02062 www.ins1.org JIN-D-15-00057.indd 1 05/01/16 11:30 PM The Art and Science of Infusion Nursing Infusion Therapy Standards of Practice Reviewers Jeanette Adams, PhD, RN, ACNS-BC, CRNI® Alicia Mares, BSN, RN, CRNI® Steve Bierman, MD Britt Meyer, MSN, RN, CRNI®, VA-BC, NE-BC Daphne Broadhurst, BScN, RN, CVAA® Crystal Miller, MA, BSN, RN, CRNI® Wes Cetnarowski, MD Diana Montez, BSN, RN Vineet Chopra, MD, MSc Tina Morgan, BSN, RN Michael Cohen, RPh, MS, ScD(hon), DPS(hon), FASHP Russ Nassof, Esq. Ann Corrigan, MS, BSN, RN, CRNI® Barb Nickel, APRN-CNS, CRNI®, CCRN Lynn Czaplewski, MS, RN, ACNS-BC, CRNI®, Shawn O’Connell, MS, RN ® AOCNS Susan Paparella, MSN, RN ® Julie DeLisle, MSN, RN, OCN Roxanne Perucca, MSN, RN, CRNI® Michelle DeVries, MPH, CIC Ann Plohal, PhD, APRN, ACNS-BC, CRNI® ® Loretta Dorn, MSN, RN, CRNI Kathy Puglise, MSN/ED, RN, CRNI® Kimberly Duff, BSN, RN Vicky Reith, MS, RN, CNS, CEN, APRN-BC ® Cheryl Dumont, PhD, RN, CRNI Claire Rickard, PhD, RN ® Beth Fabian, BA, RN, CRNI Robin Huneke Rosenberg, MA, RN-BC, CRNI®, Stephanie Fedorinchik, BSN, RN, VA-BC VA-BC Michelle Fox, BSN, RN Diane Rutkowski, BSN, RN, CRNI® Marie Frazier, MSN, RN, CRNI® Laura Rutledge, MN, RN, CRNI® Claudia Freitag, PhD Ofelia Santiago, BSN, RN, CRNI® Doreen Gendreau, MSN, MS, CNS, RN-BC, CWCN, Liz Sharpe, DNP, ARNP, NNP-BC, VA-BC DAPWCA Marvin Siegel, RN, CRNI® Lynn Gettrust, MSN, RN Marc Stranz, PharmD Connie Girgenti, BSNc, RN, VA-BC Tim Vanderveen, PharmD, MS Sheila Hale, BSN, RN, CRNI® , VA-BC Cora Vizcarra, MBA, BSN, RN, CRNI®, VA-BC ® ® Dora Hallock, MSN, RN, CRNI , OCN , CHPN Paula Foiw Washesky, MBA, RD, LDN ® Max Holder, BSN, RN, CEN, CRNI , VA-BC Steve Weber ® ® Pamela Jacobs, MHA, BSN, RN, CRNI , OCN Sharon Weinstein, MS, RN, CRNI®, CSP, FAAN, James Joseph, MPH, BSN, RN, CRNI®, VA-BC FACW Matthias Kahl Marcia Wise, RN, VA-BC Pat Kienle, RPh, MPA, FASHP Cheryl Wozniak Melissa Leone, BSN, RN Mary Zugcic, MS, RN, ACNS-BS, CRNI® Michelle Mandrack, MSN, RN JIN-D-15-00057.indd 2 05/01/16 11:30 PM Journal of Infusion Nursing JANUARY/FEBRUARY 2016 Volume 39 • Number 1S Editor Editorial Reviewers Peggy Link, MSN, RN, CRNI® Mary Alexander, MA, RN, Mohammad Abdollahi, PharmD, PhD Rose Anne Lonsway, MA, BSN, CRNI® CRNI®*, CAE, FAAN Jeanette Adams, PhD, RN, Lisa P. L. Low, MPhil, BN, RHV, RN ACNS-BC, CRNI® Lauro Manalo, Jr, MSN Managing Editor Rhonda Maneval, DEd Dorothy Lohmann Melissa Adler, MSN, RN, CMSRN, OCN® Mary McGoldrick, MS, RN, CRNI® ® Editorial Offices Christopher Basnett, MSN, RN, Britt Meyer, MSN, RN, CRNI , INS CRNI®, FNP-BC VA-BC, NE-BC ® ® 315 Norwood Park South Deborah Benvenuto, MBA, BS, CRNI® Nancy Mortlock, RN, CRNI , OCN , Norwood, MA 02062 Georgene Bloomfield, RPh, MS CSRN (781) 440–9408 ® Wendy L. Boersma, BSN, RN, CRNI® Inez Nichols, MSN, RN, CRNI , Fax: (781) 440–9409 Elizabeth Ann Bonilla, MEd, BSN FNP-BC ® For advertising information: Tammy Burdeaux, RN, CRNI® Julie D. Painter, MSN, RN, OCN Nicholas Cardinale, RN, CRNI® Alvisa Palese, MSN Product Advertising Susan Paparella, MSN, RN Michelle Smith, Senior Account Pamela Clark, BSN ® ® Lorelei Papke, MSN, CEd, CRNI Manager Lynda Cook, MSN, RN, CRNI France Paquet, MScN [email protected] Nancy Corbitt, BSN, RN, OCN®, CRNI® Evridiki E. Patelarou, PhD (646) 674-6537 Ann M. Corrigan, MS, BSN, CRNI® Michael Perlow, DNS, RN Judybeth Crowell, BSN, RN, Recruitment Advertising Roxanne Perucca, MS, RN, CRNI® CRNI® North/East: Mike Rusch, Field Cynthia Peterson, MS, RN Kate Douglass, MS, C, CNS, CRNI® Sales Rep Lynn Phillips, MSN, RN, CRNI® Cheryl J. Dumont, PhD, RN, CRNI® [email protected] Christine Pierce, MSN, RN, FACHE Beth Fabian, BA, CRNI® (215) 521-8404 Susan Markel Poole, MS, BSN, Rebecca Anne French, DNP, MSN, South/East: Linda Barta, Regional CRNI®, CNSN BS, RN, CRNI®, ARNP-C Sales Manager Jennifer Riesenberg, BSN, RN, CRNI® Anne Marie Frey, BSN, RN, CRNI® [email protected] Robin Elizabeth Huneke Rosenberg, Nancy Fusillo, MSN, ARNP-BC, (800) 237-1342 MA, RN-BC, CRNI®, VA-BC OCN®, CRNI® West: Michaela Taylor, Advertising Kellianne C. Rosenthal, MS, RN, Sales Rep John Hudson Garrett, Jr, PhD, MSN, CRNI®, ANP, APRN, BC [email protected] MPH, APRN, FNP, CSRN, Timothy Royer, BSN (415) 603-9197 VA-BC™, DON-CLTC™, C-NAC™ ® Jodie Lockman-Samkowiak, DNP, Tracey C. Gaslin, MSN, CRNI , CPNP RN, CRNI® INS Board of Directors Catherine Ann Guy, BSN Fe San Angel, BSN, RN, CRNI®, ® President Lynn C. Hadaway, MEd, RN-BC, CRNI OCN® Cheryl Dumont, PhD, RN, CRNI® Dora Hallock, MSN, RN Felicia Schaps, BSN, RN, CRNI®, ® Donna Hammond, RN, CRNI OCN®, CNSC, CQA President-Elect ® Richelle Hamblin, MSN, RN, CRNI®, Judy Hankins, BSN, RN, CRNI Marvin Siegel, RN, CRNI® RN-BC Michelle L. Hawes, MSN, RN, Kevin Stansbury, MBA, RN CRNI®, VA-BC Presidential Advisor Sandeep Tripathi, MD Mark R. Hunter, RN, CRNI® ® Ann Plohal, PhD, APRN, ACNS-BC, Cora Vizcarra, MBA, RN, CRNI Debra Johnson, MPH, BSN, RN, CRNI® Susan H. Weaver, MSN, RN, OCN®, CIC NEA-BC, CRNI® Secretary/Treasurer ® ® Sarah M. Jones, MS, RN, ACNS- Sharon M. Weinstein, MS, CRNI , Lisa Bruce, BSN, RN, CRNI , IgCN ® ® BC, AOCNS , CRNI FAAN Directors-at-Large Alene J. Keller, BSN, RN, CRNI® Judy G. Williams, BA, RN, CRNI® ® Diedre Bird, BSN, RN, CRNI Edward Korycka, CRNI®, OCN® Kathleen Wilson, MPH, BSN, RN, Max Holder, BSN, RN, CEN, ® ® Dana Kyles, BSN CRNI CRNI , VA-BC James Lacy, BSN, RN, CRNI® Ann Zonderman, JD, BSN, CRNI® Public Member Helen Larson, BSN, RN, CRNI® Mary Zugcic, MS, RN, ACNS-BC, Donald Filibeck, PharmD, MBA CRNI® INS Chief Executive Officer *CRNI is a registered trademark of the Infusion Nurses Certification Corporation. Mary Alexander, MA, RN, CRNI®, The Journal of Infusion Nursing, the official publication of the Infusion Nurses Society (INS), seeks to promote excellence in infusion CAE, FAAN nursing by presenting new research, clinical reviews, case studies, and professional development information relevant to the practice of infusion therapy. Articles selected for publication represent the broad scope of the infusion specialty and draw on the expertise of all health care providers who participate in the delivery of infusion. JIN-D-15-00057.indd 3 05/01/16 11:30 PM Journal of InfusionInfusion NursingNursing Contents Note: The “S” in page numbers denotes supplement issue and does not refer to a specifi c standard. Foreword S1 SECTION THREE: III. Central Venous Access via Peripherally Inserted About the Standards of INFECTION PREVENTION Central Catheters S55 Practice Committee S3 AND CONTROL IV. Central Venous Access Preface S5 16. Hand Hygiene S38 via Nontunneled Central A Message from BD Medical S6 17. Compounding and Preparation of Vascular Access Devices (CVADs) S55 Acknowledgments S7 Parenteral Solutions and Medications S39 V. Central Venous Access via Methodology for Developing the 18. Medical Waste and Sharps Tunneled Central Vascular Standards of Practice S8 Safety S40 Access Devices (CVADs) Strength of the Body of Evidence S10 and Implanted Ports S55 19. Standard Precautions S41 VI. Peripheral Arterial Access S55 20. Transmission-Based Precautions S42 STANDARDS OF PRACTICE VII. External Jugular Vein 21. Disinfection of Durable Medical Access S56 Equipment S43 SECTION ONE: INFUSION 28. Implanted Vascular Access THERAPY PRACTICE SECTION FOUR: INFUSION Ports S58 1. Patient Care S11 EQUIPMENT 29. Hemodialysis Vascular Access Devices (VADs) S59 2. Special Patient Populations S11 22.
Recommended publications
  • Curriculum Vitae MICHAEL J

    Curriculum Vitae MICHAEL J

    Curriculum Vitae MICHAEL J. KREMER, PhD, CRNA, CHSE, FNAP, FAAN BUSINESS ADDRESS: Rush University College of Nursing/Rush Center for Clinical Skills and Simulation 600 S. Paulina St., #1034/1750 W. Harrison St., KP 192 Chicago, IL 60612-3833 Phone: 312.942.6125 E-mail: Mike [email protected] EDUCATION 1997-1998 Post-doctoral research fellow, psychoneuroimmunology, Rush University College of Nursing. NINR-funded institutional training grant #T32NR07052, “Clinical Symptoms with Potential for Immunosuppression.” 1993-1997 PhD, Rush University College of Nursing, Chicago, Illinois. Recipient, Nurse Anesthetist Faculty Fellowship funds from U.S. Department of Health and Human Services, #2A22NU50026-02. Dissertation: A Study of Clinical Decision Making by Nurse Anesthetists 1989-1991 M.S.N., Nursing Leadership, Seattle Pacific University, Seattle, Washington. 1979-1981 B.S., Nurse Anesthesia, University of Illinois – Springfield (formerly Sangamon State University) Certificate, St. John’s Hospital, Springfield, Illinois. 1975-1978 B.S., Nursing, Northern Illinois University, DeKalb, Illinois 1971-1975 B.A., Psychology, Northern Illinois University, DeKalb, Illinois PROFESSIONAL EXPERIENCE 2018-present Professor, Adult Health & Gerontological Nursing, Rush University College of Nursing; Professor, Nursing Division, Rush University Graduate College 2020-2021: Chair, College of Nursing Admissions and Progressions Committee 2020: Member, Adult Health and Gerontological Nursing Chair Search Committee 2019: Chair, Rush University Library Director
  • Intravenous Therapy Procedure Manual

    Intravenous Therapy Procedure Manual

    INTRAVENOUS THERAPY PROCEDURE MANUAL - 1 - LETTER OF ACCEPTANCE __________________________________________ hereby approves (Facility) the attached Reference Manual as of _____________________. (Date) The Intravenous Therapy Procedure Manual will be reviewed at least annually or more often when deemed appropriate. Revisions will be reviewed as they occur. Current copies of the Intravenous Therapy Procedure Manual shall be maintained at each appropriate nursing station. I have reviewed this manual and agree to its approval. __________________________ (Administrator) __________________________ (Director of Nursing) __________________________ (Medical Director) - 2 - TABLE OF CONTENTS TABLE OF CONTENTS INTRODUCTION A. Purpose 1 B. Local Standard of Practice 1 RESPONSIBILITIES A. Responsibilities: M Chest Pharmacy 1 B. Responsibilities: Administrator 1 C. Responsibilities: Director of Nursing Services (DON/DNS) 1 D. Skills Validation 2 AMENDMENTS GUIDELINES A. Resident Candidacy for IV Therapy 1 B. Excluded IV Medications and Therapies 1 C. Processing the IV Order 1 D. IV Solutions/Medications: Storage 2 E. IV Solutions/Medications: Handling 3 F. IV Solutions and Supplies: Destroying and Returning 4 G. IV Tubing 5 H. Peripheral IV Catheters and Needles 6 I. Central Venous Devices 7 J. Documentation and Monitoring 8 K. IV Medication Administration Times 9 L. Emergency IV Supplies 10 I TABLE OF CONTENTS PROTOCOLS A. IV Antibiotic 1 1. Purpose 2. Guidelines 3. Nursing Responsibilities B. IV Push 2 1. Purpose 2. Guidelines C. Anaphylaxis Allergic Reaction 4 1. Purpose 2. Guidelines 3. Nursing Responsibilities and Interventions 4. Signs and Symptoms of Anaphylaxis 5. Drugs Used to Treat Anaphylaxis 6. Physician Protocol PRACTICE GUIDELINES A. Purpose 1 B. Personnel 1 C. Competencies 1 D.
  • Pictures of Central Venous Catheters

    Pictures of Central Venous Catheters

    Pictures of Central Venous Catheters Below are examples of central venous catheters. This is not an all inclusive list of either type of catheter or type of access device. Tunneled Central Venous Catheters. Tunneled catheters are passed under the skin to a separate exit point. This helps stabilize them making them useful for long term therapy. They can have one or more lumens. Power Hickman® Multi-lumen Hickman® or Groshong® Tunneled Central Broviac® Long-Term Tunneled Central Venous Catheter Dialysis Catheters Venous Catheter © 2013 C. R. Bard, Inc. Used with permission. Bard, are trademarks and/or registered trademarks of C. R. Bard, Inc. Implanted Ports. Inplanted ports are also tunneled under the skin. The port itself is placed under the skin and accessed as needed. When not accessed, they only need an occasional flush but otherwise do not require care. They can be multilumen as well. They are also useful for long term therapy. ` Single lumen PowerPort® Vue Implantable Port Titanium Dome Port Dual lumen SlimPort® Dual-lumen RosenblattTM Implantable Port © 2013 C. R. Bard, Inc. Used with permission. Bard, are trademarks and/or registered trademarks of C. R. Bard, Inc. Non-tunneled Central Venous Catheters. Non-tunneled catheters are used for short term therapy and in emergent situations. MAHURKARTM Elite Dialysis Catheter Image provided courtesy of Covidien. MAHURKAR is a trademark of Sakharam D. Mahurkar, MD. © Covidien. All rights reserved. Peripherally Inserted Central Catheters. A “PICC” is inserted in a large peripheral vein, such as the cephalic or basilic vein, and then advanced until the tip rests in the distal superior vena cava or cavoatrial junction.
  • Scope of Practice Statements

    Scope of Practice Statements

    Scope of Practice Statements Emergency Medical Services Authority California Health and Human Services Agency EMSA # 300 November 2017 HOWARD BACKER, MD, MPH, FACEP DIRECTOR DANIEL R. SMILEY CHIEF DEPUTY DIRECTOR SEAN TRASK DIVISION CHIEF EMSA # 300 Released November 2017 EMSA #300 • Page 1 Table of Contents Introduction ........................................................................................................................................... 4 The EMS Authority ................................................................................................................................ 4 Local EMS Agencies ............................................................................................................................. 4 California EMS Personnel Levels .......................................................................................................... 4 Reading the Scope of Practice Pages .................................................................................................. 5 Airway and Breathing ............................................................................................................................ 6 Airway Suctioning .............................................................................................................................. 7 Automatic Transport Ventilator .......................................................................................................... 8 Bag Valve Mask – BVM ....................................................................................................................
  • The Emergency Severity Index

    The Emergency Severity Index

    The Emergency Severity Index Jassin M. Jouria, MD Dr. Jassin M. Jouria is a medical doctor, professor of academic medicine, and medical author. He graduated from Ross University School of Medicine and has completed his clinical clerkship training in various teaching hospitals throughout New York, including King’s County Hospital Center and Brookdale Medical Center, among others. Dr. Jouria has passed all USMLE medical board exams, and has served as a test prep tutor and instructor for Kaplan. He has developed several medical courses and curricula for a variety of educational institutions. Dr. Jouria has also served on multiple levels in the academic field including faculty member and Department Chair. Dr. Jouria continues to serve as a Subject Matter Expert for several continuing education organizations covering multiple basic medical sciences. He has also developed several continuing medical education courses covering various topics in clinical medicine. Recently, Dr. Jouria has been contracted by the University of Miami/Jackson Memorial Hospital’s Department of Surgery to develop an e- module training series for trauma patient management. Dr. Jouria is currently authoring an academic textbook on Human Anatomy & Physiology. Abstract One of the main challenges encountered by emergency departments is determining how to appropriately triage patients. Although some systems only take into account a single determining factor, the Agency for Healthcare Research and Quality promotes a system that considers both the acuity of patients’ health care problems as well as the number of resources needed to treat them. This system provides emergency departments with a unique tool to ensure that the most at-risk patients are being seen and treated in the most efficient manner.
  • Attachment 3

    Attachment 3

    CURRICULUM CLINICAL BASE / CA-1 / CA-2 / CA-3 ANESTHESIOLOGY RESIDENCY PROGRAM GOALS AND OBJECTIVES AND CORE COMPETENCIES Department of Anesthesiology University of Missouri at Kansas City School of Medicine Saint Luke’s Hospital Truman Medical Center Children’s Mercy Hospital Revised 2011 Table of Contents Pages Introduction – Statement of Curriculum ................................................................................................................... 3 I. Rendering Patient Insensible to Pain ............................................................................................................. 4-10 II. Support of Life Functions ............................................................................................................................. 11-16 III. Clinical Base Year A. Cardiology ................................................................................................................................................. 17-32 B. Emergency Medicine ................................................................................................................................. 33-44 C. General Medicine ....................................................................................................................................... 45-49 D. Infectious Disease ...................................................................................................................................... 50-59 E. Nephrology ..............................................................................................................................................
  • Antimicrobial Stewardship Guidance

    Antimicrobial Stewardship Guidance

    Antimicrobial Stewardship Guidance Federal Bureau of Prisons Clinical Practice Guidelines March 2013 Clinical guidelines are made available to the public for informational purposes only. The Federal Bureau of Prisons (BOP) does not warrant these guidelines for any other purpose, and assumes no responsibility for any injury or damage resulting from the reliance thereof. Proper medical practice necessitates that all cases are evaluated on an individual basis and that treatment decisions are patient-specific. Consult the BOP Clinical Practice Guidelines Web page to determine the date of the most recent update to this document: http://www.bop.gov/news/medresources.jsp Federal Bureau of Prisons Antimicrobial Stewardship Guidance Clinical Practice Guidelines March 2013 Table of Contents 1. Purpose ............................................................................................................................................. 3 2. Introduction ...................................................................................................................................... 3 3. Antimicrobial Stewardship in the BOP............................................................................................ 4 4. General Guidance for Diagnosis and Identifying Infection ............................................................. 5 Diagnosis of Specific Infections ........................................................................................................ 6 Upper Respiratory Infections (not otherwise specified) ..............................................................................
  • Nicotine Patches Appear Safe for CAD Patients

    Nicotine Patches Appear Safe for CAD Patients

    May 1, 2007 • www.internalmedicinenews.com Cardiovascular Medicine 37 Nicotine Patches Appear Safe for CAD Patients BY BRUCE JANCIN 30%, but many physicians have been re- induced myocardial defect on single-photon ment arm jumped from 10.9 to 25.2 Denver Bureau luctant to recommend it for their patients emission computed tomography (SPECT) ng/mL, Dr. Leja said. After 1 week, patients with coronary artery disease (CAD) be- to receive either 21-mg nicotine patches or were encouraged to quit smoking while N EW O RLEANS — Nicotine patches cause nicotine is known to increase heart placebo in addition to continuing their usu- continuing to use their assigned patches. are safe for use in smokers with known rate and blood pressure, and can induce al amount of cigarette smoking. The pri- Upon SPECT imaging at week 4, the coronary artery disease and stress-induced vasoconstriction as well, Dr. Monika J. Leja mary end point of the study was change in size of the perfusion defects in the nico- myocardial ischemia, according to the re- reported at the annual scientific session of total perfusion defect size upon repeat stress tine patch group remained unchanged sults of the first-ever randomized, place- the American College of Cardiology. SPECT imaging performed at 1 week. from baseline, although their plasma nico- bo-controlled, multicenter clinical trial to Dr. Leja and her coinvestigators at the There was no change in the total or is- tine levels remained as high as at week 1. examine this issue. Methodist DeBakey Heart Center in Hous- chemic perfusion defect size, compared The trial was supported by Glaxo- Nicotine replacement therapy doubles ton randomized 55 heavy smokers with with baseline, in either group even though SmithKline Consumer Healthcare.
  • Emergency Medical System 2021 Patient Treatment Protocols

    Emergency Medical System 2021 Patient Treatment Protocols

    2021 Patient Treatment Protocols Effective January 1, 2021 CONTENTS Table of Contents Preface Section ...........................................................................................................00.000 EMS Provider Scope of Practice and Nomenclature .....................................................00.010 Death in the Field ........................................................................................................00.020 Dying and Death, POLST, Do Not Attempt Resuscitation Orders ..............................00.030 Medical Control for Drugs and Procedures ..................................................................00.040 Treatment ......................................................................................................... Section 10.000 Abdominal Pain ...........................................................................................................10.010 Altered Mental Status and Coma ..................................................................................10.020 Anaphylaxis and Allergic Reaction ................................................................................10.030 Burns ...........................................................................................................................10.040 Cardiac Arrest ..............................................................................................................10.050 Emergency Medical Responder/EMT Paramedic/EMT-Intermediate Quick Reference to Pediatric Drugs Cardiac Dysrhythmias ..................................................................................................10.060
  • Portsmouth Healthcare NHS Trust

    Portsmouth Healthcare NHS Trust

    DOH601899-0001 Portsmouth HealthCare NHS Trust One Year On: Aspects of Clinical Nursing Governance in the Department of Elderly Medicine Eileen Thomas September 2001 DOH601899-0002 Executive Summary This summary reports the findings of a review into aspects of clinical nursing governance in the Department of Elderly Medicine, Portsmouth HealthCare NHS Trust. The same methods were used as those in an initial review conducted between January and May 2000. This first review was instigated as a result of high staff turnover and recruitment difficulties which had implications for bed availability and care quality. As a consequence of the first review, many changes have been implemented. There was clear evidence of increased responsiveness to staff requests for different ways of working, and several statistical indicators demonstrated improvements. A new clinical career structure had enabled clinical supervision to be developed and in general morale throughout the division was much higher than it had been previously. The NHS modernisation agenda requires that more improvements are made in the future. espcially those based around patient care needs. The report recommends some ways in which the division can rise to meet these challenges in the future DOH601899-0003 1. Introduction 1.1 During the early months of 2000, a review was conducted into aspects of Clinical Nursing Governance in the Department of Elderly Medicine, Portsmouth HealthCare NHS Trust. It was instigated primarily as a result of short term bed closures which occurrred as a result of high turnover and nursing recruitment difficullties. The subsequent report made a number of recommendations and provided several learning points for the division.
  • General a Number of Factors Could Reduce the Efficacy of This

    General a Number of Factors Could Reduce the Efficacy of This

    AUSTRALIAN PRODUCT INFORMATION Administration It is strongly recommended that every time that GAMUNEX® is administered to a patient, the name Use in the elderly GAMUNEX® If dilution is required, GAMUNEX® may be diluted with 5% dextrose in water (D5/W). Do not and batch number of the product are recorded using the supplied tear off labels in order to maintain See Section 4.4 Special warnings and precautions for use: Use in renal impairment. a link between the patient and the batch of the product. (NORMAL IMMUNOGLOBULIN (HUMAN), 10%, INTRAVENOUS SOLUTION VIAL) dilute with saline. Paediatric use Anaphylaxis GAMUNEX® should be inspected visually for particulate matter and discoloration prior to adminis - No data available. GAMUNEX® should be administered only intravenously or subcutaneously. On rare occasions, tration, whenever solution and container permit. Do not use if turbid and/or if discoloration is Effects on laboratory tests 1 NAME OF THE MEDICINE observed. treatment with an immune globulin preparation may cause a precipitous fall in blood pressure and a Interference with serological testing Normal immunoglobulin (Human), 10%, for Intravenous or Subcutaneous Administration For intravenous or subcutaneous administration, GAMUNEX® should be at room temperature during clinical picture of anaphylaxis, even when the patient is not known to be sensitive to immune globulin administration. preparations. Adrenalin and other appropriate supportive care should be available for the treatment After injection of immunoglobulin the transitory rise of the various passively transferred antibodies of an acute anaphylactic reaction. in the patient’s blood may result in misleading positive results in serological testing. Passive Intravenous (IV) True anaphylactic reactions to GAMUNEX® may occur in recipients with documented prior histories transmission of antibodies to erythrocyte antigens e.g.
  • Foundations for Gerontological Nursing

    Foundations for Gerontological Nursing

    © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION Unit I © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION FoundationsNOT FOR SALE OR DISTRIBUTION for Gerontological Nursing © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT (COMPETENCIES FOR SALE OR DISTRIBUTION 1, 8, 9, 19) CHAPTER 1 INTRODUCTION TO GERONTOLOGICAL © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE ORNURSING DISTRIBUTION (COMPETENCIESNOT FOR 1, SALE9, 19) OR DISTRIBUTION CHAPTER 2 THE AGING POPULATION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION (COMPETENCIESNOT FOR SALE OR 1,DISTRIBUTION 8, 19) CHAPTER 3 THEORIES OF AGING © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE (COMPETENCYOR DISTRIBUTION 19) © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Mario Lopes/ShutterStock, Inc. Mario Lopes/ShutterStock, © © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC© Jones & Bartlett Learning, LLC.© NOTJones FOR SALE& Bartlett OR DISTRIBUTION Learning, LLC NOT FOR SALE OR DISTRIBUTION